In EMEA, Boston Scientific (BSX) is expected to have registered growth within structural heart, including Transcatheter aortic valve replacement, WATCHMAN…
Within Neuromodulation, Boston Scientifics pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.…
New York (www.aktiencheck.de) - Stryker-Aktienanalyse von Evercore ISI:
Die Analysten von Evercore ISI stufen die Aktie von Stryker Corp. (ISIN: US8636671013,…